[Resection and reconstruction of the retrohepatic vena cava in combination with liver resections].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 15849651)

Published in Zentralbl Chir on April 01, 2005

Authors

U Settmacher1, A Thelen, S Jonas, I Husmann, M Heise, P Neuhaus

Author Affiliations

1: Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Campus Virchow Klinikum, Charité, Humboldt Universität zu Berlin. utz.settmacher@charite.de

Articles by these authors

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology (2001) 3.26

Retracted Long-term results and risk factors influencing outcome of major bile duct injuries following cholecystectomy. Br J Surg (2005) 3.06

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics (2001) 3.05

Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93

Sexual segregation in ungulates: a comparative test of three hypotheses. Biol Rev Camb Philos Soc (2002) 2.34

A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24

The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics (2001) 2.21

The impact of carbon dioxide pneumoperitoneum on liver regeneration after liver resection in a rat model. Surg Endosc (2009) 2.16

Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology (1998) 1.98

Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy. J Hepatol (2010) 1.95

Rosiglitazone reduces urinary albumin excretion in type II diabetes. J Hum Hypertens (2003) 1.95

Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant (2008) 1.86

Management and outcome of patients with combined bile duct and hepatic arterial injuries after laparoscopic cholecystectomy. Surgery (2004) 1.82

Isolation of viruses from specimens submitted for direct immunofluorescence test for respiratory syncytial virus. J Pediatr (1986) 1.78

Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg (2008) 1.74

Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. Am J Transplant (2008) 1.67

C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant (2006) 1.62

Hepatocellular carcinoma in association with hepatic focal nodular hyperplasia. Acta Radiol (2006) 1.59

The Drosophila lethal(2)giant larvae tumor suppressor protein forms homo-oligomers and is associated with nonmuscle myosin II heavy chain. J Cell Biol (1994) 1.59

Exhaled nitric oxide in childhood asthma. Eur J Pediatr (1996) 1.57

Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance. Diabet Med (2004) 1.54

A theoretical approach to the question of "community control" of health services facilities. Am J Public Health (1971) 1.54

Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant (2013) 1.54

[S3-Guidelines "Exocrine pancreatic cancer" 2007]. Z Gastroenterol (2007) 1.52

Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation. Radiology (1997) 1.52

Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51

Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization. Radiology (1998) 1.49

Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology (2000) 1.48

Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int (1996) 1.47

The laparoscopic Janeway gastrostomy. An alternative technique when percutaneous endoscopic gastrostomy is impractical. Endoscopy (2001) 1.46

Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol (2005) 1.46

Management and outcomes of haemorrhage after pancreatogastrostomy versus pancreatojejunostomy. Br J Surg (2011) 1.46

Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46

Experiences with liver transplantation in Hannover. Hepatology (1984) 1.45

Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J Lipid Res (1994) 1.44

Venous complications after orthotopic liver transplantation. Clin Transplant (2000) 1.43

Discontinuation of antistreptococcal prophylaxis. A double-blind study in rheumatic patients free of heart disease. JAMA (1966) 1.42

Diagnosis of enteroceles by dynamic anorectal endosonography. Dis Colon Rectum (2000) 1.40

Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg (2001) 1.40

[Simulation of a colon carcinoma: diuretic-induced ulcerative-stricturing ischemic colitis]. Dtsch Med Wochenschr (2004) 1.39

[Mesenteric artery occlusion as a rare complication of thromboangiitis obliterans]. Chirurg (2002) 1.38

On homelessness and the American way. Am J Public Health (1986) 1.38

Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation (2001) 1.38

Donor criteria in hepatic transplantation. Langenbecks Arch Chir (1994) 1.38

High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer (2007) 1.37

Constitutive activity of the light-sensitive channels TRP and TRPL in the Drosophila diacylglycerol kinase mutant, rdgA. Neuron (2000) 1.36

Clinical extracorporeal hybrid liver support--phase I study with primary porcine liver cells. Xenotransplantation (2003) 1.35

Chronic recurrent multifocal osteomyelitis in children. Pediatr Infect Dis J (1999) 1.34

Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization. Transplant Proc (1987) 1.30

Appointment-breaking in a general medical clinic. Med Care (1971) 1.30

Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant (2013) 1.29

Magnetic inversion symmetry breaking and ferroelectricity in TbMnO3. Phys Rev Lett (2005) 1.29

Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant (2007) 1.26

Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant (2005) 1.26

Limitations of community control of health facilities and services. Am J Public Health (1978) 1.25

Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut (1996) 1.22

Regulatory peptide receptors in human hepatocellular carcinomas. Gut (1999) 1.22

Transabdominal ligation of the thoracic duct as treatment of choice for postoperative chylothorax after esophagectomy. Dis Esophagus (2007) 1.19

Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest (1992) 1.17

Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology (1992) 1.13

Further evidence for the efficacy of a metacognitive group training in schizophrenia. Behav Res Ther (2010) 1.13

Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation. Transplant Proc (1999) 1.09

Liver resection for metastases from renal cell carcinoma. World J Surg (2007) 1.09

[Therapy of primary hepatocellular carcinoma]. Dtsch Med Wochenschr (1997) 1.08

[Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres]. Z Gastroenterol (2011) 1.07

De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer (1997) 1.06

[Diagnostic imaging of hepatocellular carcinoma]. Dtsch Med Wochenschr (1997) 1.06

The influence of OKT8F treatment on allograft survival in rhesus monkeys. Transplantation (1986) 1.06

Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis. Br J Cancer (2003) 1.05

Selective labelling of lymphoid tissues by extracorporeal perfusion. J Immunol Methods (1980) 1.05

The supplementary motor region and speech emission. J Commun Disord (1981) 1.04

Surgical complications and long-term outcome of different biliary reconstructions in liver transplantation for primary sclerosing cholangitis-choledochoduodenostomy versus choledochojejunostomy. Am J Transplant (2006) 1.04

Noninvasive analysis of conjunctival microcirculation during carotid artery surgery reveals microvascular evidence of collateral compensation and stenosis-dependent adaptation. J Vasc Surg (2003) 1.03

Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg (2000) 1.02

Extended resections of liver metastases from colorectal cancer. World J Surg (2007) 1.00

Results of biliary reconstruction after liver transplantation. Transplant Proc (1984) 1.00

What can be learned from brain-death models? Transpl Int (2005) 0.99

A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transpl (2001) 0.99

Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. Eur J Endocrinol (2013) 0.99

Survival after liver transplantation for hepatocellular carcinoma in cirrhosis according to the underlying liver disease. Transplant Proc (2001) 0.99

Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation (1994) 0.99

Polyunsaturated fatty acids inhibit S14 gene transcription in rat liver and cultured hepatocytes. Proc Natl Acad Sci U S A (1993) 0.99

Primary human liver cells as source for modular extracorporeal liver support--a preliminary report. Int J Artif Organs (2002) 0.99

Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation. Transplantation (1995) 0.98

Repeat liver resection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol (2006) 0.97

[Metastatic lesions to the pancreas. When is resection reasonable?]. Chirurg (2008) 0.97